{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:10:32Z","timestamp":1791900632084,"version":"4.3.4"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejmech.2013.09.050","type":"journal-article","created":{"date-parts":[[2013,10,6]],"date-time":"2013-10-06T10:01:27Z","timestamp":1381053687000},"page":"165-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":328,"special_numbering":"C","title":["Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection"],"prefix":"10.1016","volume":"70","author":[{"given":"Manjinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maninder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Kukreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.09.050_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archopht.1964.00970020113023","article-title":"I\u00a0saw for the first time in front of both my eyes the ominous colored halos","volume":"72","author":"Snyder","year":"1964","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib2","series-title":"Organophosphorus Pesticides: Organic and Biological Chemistry","first-page":"57","author":"Eto","year":"1974"},{"key":"10.1016\/j.ejmech.2013.09.050_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5702\/massspec.44.293","article-title":"Basic information on nerve gas and the use of sarin by Aum Shinrikyo","volume":"44","author":"Tu","year":"1996","journal-title":"J.\u00a0Mass Spectrom. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2013.09.050_bib4","series-title":"Chemical Warfare Agents: Toxicology and Treatment","first-page":"83","article-title":"Organophosphates nerve agents","author":"Marrs","year":"1996"},{"key":"10.1016\/j.ejmech.2013.09.050_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1081\/CLT-120015840","article-title":"Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents","volume":"40","author":"Kassa","year":"2002","journal-title":"J.\u00a0Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/349043","article-title":"Prelude to the discovery of penicillin","volume":"40","author":"Landsberg","year":"1949","journal-title":"Isis"},{"key":"10.1016\/j.ejmech.2013.09.050_bib7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/0169-5347(88)90128-0","article-title":"Current applied recombinant DNA projects","volume":"3","author":"Gaertner","year":"1988","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s100480050033","article-title":"Histopathology and APOE genotype of the first Alzheimer's disease patient Auguste D","volume":"1","author":"Graeber","year":"1998","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ejmech.2013.09.050_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","article-title":"Developing \u03b2-secretase inhibitors for treatment of Alzheimer's disease","volume":"1","author":"Ghosh","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib10","first-page":"1","article-title":"Novel \u03b3-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012","volume":"23","author":"Pettersson","year":"2013","journal-title":"Neurosci. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib11","unstructured":"W.K. Summers, Administration of monoamine acridines in cholinergic neuronal deficit states, US 4816456, 1989."},{"key":"10.1016\/j.ejmech.2013.09.050_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1474-4422(11)70158-2","article-title":"Functional network disruption in the degenerative dementias","volume":"10","author":"Pievani","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib13","series-title":"Textbook of Clinical Neurology","first-page":"699","article-title":"The degenerative dementias","author":"Caselli","year":"2007"},{"key":"10.1016\/j.ejmech.2013.09.050_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A\u00a0century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.09.050_bib15","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/jm701225u","article-title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib16","first-page":"198","article-title":"Cognitive deficits in the early stages of Alzheimer's disease","volume":"17","author":"Storandt","year":"2008","journal-title":"Assoc. Psychol. Sci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nlm.2004.06.005","article-title":"Memory systems of the brain: a brief history and current perspective","volume":"82","author":"Squire","year":"2004","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00424-009-0736-1","article-title":"Calcium hypothesis of Alzheimer's disease","volume":"459","author":"Berridge","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ejmech.2013.09.050_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archneur.1969.00480130123013","article-title":"Alzheimer's disease","volume":"21","author":"Wilkins","year":"1969","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib20","first-page":"146","article-title":"Over a eigenartigo disease of the cerebral cortex","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Z. Psychiat."},{"key":"10.1016\/j.ejmech.2013.09.050_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/1921227a0","article-title":"General nature of the genetic code for proteins","volume":"192","author":"Crick","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2013.09.050_bib22","first-page":"269","article-title":"Ultrastructural studies in Alzheimer's presenile dementia","volume":"44","author":"Terry","year":"1964","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00005072-196310000-00005","article-title":"The fine structure of neurofibrillary tangles in Alzheimer's disease","volume":"22","author":"Terry","year":"1963","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-510X(76)90059-9","article-title":"Neurofibrillary tangles of paired helical filaments","volume":"27","author":"Wi\u015bniewski","year":"1976","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"The prevalence and malignancy of Alzheimer's disease","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib26","series-title":"Concepts of Alzheimer's Disease, Biological, Clinical, and Cultural Perspectives","first-page":"104","article-title":"The rediscovery of Alzheimer disease during the 1960s and 1970s","author":"Katzman","year":"2000"},{"key":"10.1016\/j.ejmech.2013.09.050_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-0173(94)00015-H","article-title":"Microglia: intrinsic immuneffector cell of the brain","volume":"20","author":"Gehrmann","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejmech.2013.09.050_bib28","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2013.09.050_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1212\/WNL.44.1.97","article-title":"Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial","volume":"44","author":"Prince","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2013.09.050_bib30","series-title":"Alzheimer Disease, the Changing View","first-page":"182","article-title":"The cholinergic story: hope for the patient and family","author":"Katzman","year":"2000"},{"key":"10.1016\/j.ejmech.2013.09.050_bib31","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1021\/jm900628z","article-title":"Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease","volume":"22","author":"Arce","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2013.09.050_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.09.050_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","article-title":"Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics","volume":"43","author":"Selkoe","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J.\u00a0Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-2009-1137","article-title":"A\u00a0study of the SORL1 gene in Alzheimer's disease and cognitive function","volume":"18","author":"Liu","year":"2009","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2013.09.050_bib37","doi-asserted-by":"crossref","first-page":"35789","DOI":"10.1074\/jbc.C500238200","article-title":"Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia","volume":"280","author":"Tabner","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib38","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/ars.2007.1763","article-title":"Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease","volume":"9","author":"Leuner","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejmech.2013.09.050_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/251426","article-title":"Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease","volume":"2012","author":"Crespo-Biel","year":"2012","journal-title":"Int. J. Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2013.09.050_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1750-3639.1991.tb00671.x","article-title":"Tau proteins and neurofibrillary degeneration","volume":"1","author":"Goedert","year":"1991","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2013.09.050_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2741\/2097","article-title":"The role of tau phosphorylation and cleavage in neuronal cell death","volume":"12","author":"Chun","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuint.2007.10.002","article-title":"Calcium dysregulation in Alzheimer's disease","volume":"52","author":"Bojarski","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2013.09.050_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuron.2008.07.013","article-title":"Linking calcium to A\u03b2 and Alzheimer's disease","volume":"59","author":"Green","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2013.09.050_bib45","doi-asserted-by":"crossref","first-page":"39907","DOI":"10.1074\/jbc.M606015200","article-title":"Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation","volume":"281","author":"Pierrot","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib46","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/bi00181a016","article-title":"Calcium ionophore increases amyloid beta peptide production by cultured cells","volume":"33","author":"Querfurth","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0197-0186(94)90050-7","article-title":"Isoprenoids in aging and neuro degeneration","volume":"25","author":"Edlund","year":"1994","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2013.09.050_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138161206775193127","article-title":"The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design","volume":"12","author":"Johnson","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.09.050_bib49","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1016\/S0021-9258(19)37091-7","article-title":"Mutagenesis of human acetyl cholinesterase. Identification of residue involved in the catalytic activity and in polypeptide folding","volume":"267","author":"Shafferman","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbi.2005.10.021","article-title":"Functional requirements for the optimal catalytic configuration of the AChE active center","volume":"157","author":"Shafferman","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2013.09.050_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-6576.2011.02558.x","article-title":"Anesthesia and myasthenia gravis","volume":"56","author":"Blichfeldt-Lauridsen","year":"2012","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejmech.2013.09.050_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targetting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00441-006-0239-8","article-title":"Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission","volume":"326","author":"Zimmerman","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejmech.2013.09.050_bib54","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/cr00081a005","article-title":"Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states","volume":"87","author":"Quinn","year":"1987","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2013.09.050_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.ne.05.030182.000421","article-title":"The molecular forms of cholinesterase and acetylcholinesterase in vertebrates","volume":"5","author":"Massouli\u00e9","year":"1982","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib56","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1016\/S0021-9258(17)39005-1","article-title":"Primary structures of the catalytic subunits from two molecular forms of acetylcholinesterase. A comparison of NH2-terminal and active center sequences","volume":"260","author":"MacPhee-Quigley","year":"1985","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib57","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1021\/bi00739a027","article-title":"Amino acid sequence in the region of the reactive serine residue of eel acetylcholinesterase","volume":"12","author":"Schaffer","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib58","first-page":"103","article-title":"Acetylcholinesterase","volume":"43","author":"Rosenberry","year":"1975","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib59","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1073\/pnas.90.19.9031","article-title":"Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase","volume":"90","author":"Harel","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0928-4257(98)80007-7","article-title":"Acetylcholinesterase: C-terminal domains, molecular forms and functional localization","volume":"92","author":"Massoulie","year":"1998","journal-title":"J.\u00a0Physiol. (Paris)"},{"key":"10.1016\/j.ejmech.2013.09.050_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0076-6879(82)82070-3","article-title":"Acetylcholinesterase","volume":"82","author":"Rosenberry","year":"1982","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5507\/bp.2011.036","article-title":"Cholinesterases, a target of pharmacology and toxicology","volume":"155","author":"Pohanka","year":"2011","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.ejmech.2013.09.050_bib63","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1021\/bi00551a036","article-title":"Fluorescence energy transfer on acetylcholinesterase: spatial relationship between peripheral site and active center","volume":"19","author":"Berman","year":"1980","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib64","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/bi00708a010","article-title":"Ligand binding properties of acetylcholinesterase determined with fluorescent probes","volume":"13","author":"Mooser","year":"1974","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib65","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/bi00680a029","article-title":"Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding","volume":"14","author":"Taylor","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib66","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/bi00602a019","article-title":"Fluorescent phosphonate label for serine hydrolases, pyrenebutyl methylphosphonofluoridate: reaction with acetylcholinesterase","volume":"17","author":"Berman","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib67","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1021\/bi00519a043","article-title":"Spectroscopic studies on acetylcholinestrase: influence of peripheral site occupation on active-centre conformation","volume":"20","author":"Berman","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","article-title":"Amyloid\u2013cholinesterase interactions. Implications for Alzheimer's disease","volume":"275","author":"Inestrosa","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2013.09.050_bib69","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/156802607779941215","article-title":"Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors","volume":"7","author":"Haviv","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib70","first-page":"335","article-title":"Differential effects of peripheral site ligands on Torpedo and chicken acetylcholinesterase","volume":"45","author":"Eichler","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1389557013406864","article-title":"Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment Alzheimer's disease","volume":"1","author":"Castro","year":"2001","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","article-title":"Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils","volume":"272","author":"Alvarez","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib73","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998","article-title":"Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils","volume":"18","author":"Alvarez","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib74","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A\u00a0structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2013.09.050_bib75","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetyl cholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2013.09.050_bib76","first-page":"349","article-title":"Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action","volume":"36","author":"Abramson","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/scientificamerican0194-78","article-title":"The toxins of cyanobacteria","volume":"270","author":"Carmichael","year":"1994","journal-title":"Sci. Am."},{"key":"10.1016\/j.ejmech.2013.09.050_bib78","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1021\/ja00202a057","article-title":"Anatoxin-a(s), a potent anticholinesterase from Anabaena flos-aquae","volume":"111","author":"Matsunaga","year":"1989","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.050_bib79","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0969-2126(01)00273-8","article-title":"Crystal structure of an acetylcholinesterase\u2013fasciculin complex: interaction of a three-fingered toxin from snake venom with its target","volume":"3","author":"Harel","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2013.09.050_bib80","first-page":"14","article-title":"Chemical terrorism: a primer for 2002","volume":"13","author":"Goozner","year":"2002","journal-title":"J.\u00a0Assoc. Acad. Minor. Phys."},{"key":"10.1016\/j.ejmech.2013.09.050_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-6147(97)89540-5","article-title":"The role of excitotoxicity in organophosphorous nerve agents central poisoning","volume":"18","author":"Solberg","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","article-title":"Organophosphates\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment","volume":"38","author":"Bajgar","year":"2004","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib83","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0002-9343(71)90337-8","article-title":"Poisoning due to organophosphate insecticides","volume":"50","author":"Namba","year":"1971","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.050_bib84","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0196-0644(05)81036-4","article-title":"Chemical warfare agents: II. Nerve agents","volume":"21","author":"Sidell","year":"1992","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ejmech.2013.09.050_bib85","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0749-0704(05)70374-2","article-title":"Chemical warfare: nerve agent poisoning","volume":"4","author":"Holstege","year":"1997","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.ejmech.2013.09.050_bib86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.141.3575.63","article-title":"Anticholinesterase agents","volume":"141","author":"Koelle","year":"1963","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.09.050_bib87","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0733-8627(02)00037-8","article-title":"Biologic and chemical weapons of mass destruction","volume":"20","author":"Bozeman","year":"2002","journal-title":"Emerg. Med. Clin. North Am."},{"key":"10.1016\/j.ejmech.2013.09.050_bib88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.1965.03080170042011","article-title":"An antidote to parathion poisoning: pralidoxime chloride (Protopam chloride)","volume":"192","author":"Rosenbaum","year":"1965","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2013.09.050_bib89","series-title":"Goldfrank's Toxicologic Emergencie","first-page":"1346","article-title":"Insecticides: organic phosphorus compounds and carbamates","author":"Clark","year":"2002"},{"key":"10.1016\/j.ejmech.2013.09.050_bib90","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0103-50532009000300003","article-title":"Organophosphorus compounds as chemical warfare agents: a review","volume":"20","author":"Delfino","year":"2009","journal-title":"J.\u00a0Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.050_bib91","series-title":"Higher Form of Killing: the Secret Story of Chemical and Biological Warfare","first-page":"138","author":"Paxman","year":"1982"},{"key":"10.1016\/j.ejmech.2013.09.050_bib92","unstructured":"NE Museum, R. Kuhn, Biography, http:\/\/www.nobel.se\/chemistry\/laureates\/1938\/kuhn-bio.html."},{"key":"10.1016\/j.ejmech.2013.09.050_bib93","series-title":"Medical Aspects of Chemical and Biological Warfare","first-page":"9","article-title":"History of chemical and biological warfare: an American perspective","author":"Smart","year":"1997"},{"key":"10.1016\/j.ejmech.2013.09.050_bib94","series-title":"Introduction to Insect Biology and Diversity","first-page":"279","author":"Daly","year":"1998"},{"key":"10.1016\/j.ejmech.2013.09.050_bib95","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1289\/ehp.9087245","article-title":"Mechanism of action of organophosphorus and carbamate insecticides","volume":"87","author":"Fukuto","year":"1990","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejmech.2013.09.050_bib96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.pa.21.040181.002455","article-title":"Organophosphorus ester-induced delayed neurotoxicity","volume":"21","author":"Abou-Donia","year":"1981","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/taap.1996.0158","article-title":"Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors","volume":"139","author":"Wu","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib98","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jf60183a046","article-title":"Inhibition of acetylcholinesterase from mammals and insects by carbofuran and its related compounds and their toxicities toward these animals","volume":"20","author":"Yu","year":"1972","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jat.2550140212","article-title":"Clinical effects of organophosphorus cholinesterase inhibitors","volume":"14","author":"Sidell","year":"1994","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib100","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.0b013e3181dd4423","article-title":"Occupational exposure to pesticides increases the risk of incident AD: the Cache County study","volume":"19","author":"Hayden","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2013.09.050_bib101","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S0007485300024068","article-title":"The influence of certain biological factors on the resistance of bed-bugs (Cimex lectularius, L.) to DDT","volume":"36","author":"Barnes","year":"1946","journal-title":"Bull. Entomol. Res."},{"key":"10.1016\/j.ejmech.2013.09.050_bib102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5694\/j.1326-5377.2011.tb04162.x","article-title":"A\u00a0risk for returned travellers: the \u201cpost-antibiotic era\u201d","volume":"194","author":"Arya","year":"2011","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejmech.2013.09.050_bib103","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0167-5699(92)90125-Q","article-title":"Behring's discovery of diphtheria and tetanus antitoxins","volume":"13","author":"Grundbacher","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.ejmech.2013.09.050_bib104","first-page":"62","article-title":"Historical note on poliomyelitis in Uganda","volume":"43","author":"Bain","year":"1966","journal-title":"East Afr. Med. J."},{"key":"10.1016\/j.ejmech.2013.09.050_bib105","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.09.050_bib106","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.51.5.1433","article-title":"Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology","volume":"51","author":"Keesey","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2013.09.050_bib107","first-page":"1427","article-title":"Post-synaptic potentiation: interaction between quanta of acetylcholine at the skeletal neuromuscular synapse","volume":"25","author":"Hartzell","year":"1975","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib108","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM198611133152001","article-title":"Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type","volume":"315","author":"Summers","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.050_bib109","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.050_bib110","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.bmcl.2012.01.135","article-title":"Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production","volume":"22","author":"Pham","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib111","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/jm020391n","article-title":"Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors","volume":"46","author":"Barreiro","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib112","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/1521-4184(200209)335:7<347::AID-ARDP347>3.0.CO;2-G","article-title":"Synthesis and acetylcholinesterase\/butyrylcholinesterase inhibition activity of 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro(and thieno)[2,3-b]-quinolines, and 4-amino-5,6,7,8,9-pentahydro-2,3-diphenylcyclohepta[e]furo(and thieno)-[2,3-b]pyridines","volume":"7","author":"Marco","year":"2002","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2013.09.050_bib113","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0968-0896(00)00284-4","article-title":"Synthesis and acetylcholinesterase\/butylcholinesterase inhibition activity of tacrine like analogs","volume":"9","author":"Marco","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib114","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.bmc.2004.02.017","article-title":"Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase\/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors","volume":"12","author":"Marco","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib115","first-page":"179","article-title":"Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents","volume":"61","author":"Petroianu","year":"2003","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2013.09.050_bib116","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(96)00738-8","article-title":"Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity","volume":"315","author":"Morisset","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib117","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/jm049112h","article-title":"Rational approach to discover multipotent anti-Alzheimer drugs","volume":"48","author":"Rosini","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib118","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1021\/jm0493461","article-title":"Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties","volume":"48","author":"Cappelli","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib119","doi-asserted-by":"crossref","first-page":"23646","DOI":"10.1074\/jbc.271.39.23646","article-title":"Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase","volume":"271","author":"Pang","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/jm050746d","article-title":"Novel tacrine\u2013melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties","volume":"49","author":"Rodriguez-Franco","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib121","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.bmc.2005.09.029","article-title":"Donepezil\u2013tacrine hybrid related derivatives as new dual binding site inhibitors of AChE","volume":"13","author":"Alonso","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib122","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1021\/jm8001313","article-title":"Novel donepezil-based inhibitors of acetyl-and butyrylcholinesterase and acetylcholinesterase-induced \u03b2-amyloid aggregation","volume":"51","author":"Camps","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib123","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1021\/jm00043a012","article-title":"Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase","volume":"37","author":"Villalobos","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib124","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0223-5234(00)01166-1","article-title":"N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors","volume":"35","author":"Martinez","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib125","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/jm0109356","article-title":"Synthesis and screening for antiacetylcholinesterase activity of (1-benzyl-4-oxopiperidin-3-ylidene)methylindoles and pyrroles related to donepezil","volume":"44","author":"Andreani","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib126","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1021\/jm00041a007","article-title":"Central cholinergic agents: synthesis and evaluation of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanones and their analogs as central selective acetylcholinesterase inhibitors","volume":"37","author":"Ishihara","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib127","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ejmech.2008.02.035","article-title":"Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors","volume":"44","author":"Belluti","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib128","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1021\/jm049782n","article-title":"Design, synthesis and biological evaluation of conformationally restricted rivastigmine analogues","volume":"47","author":"Bolonesi","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib129","first-page":"1899","article-title":"Oral solution containing galanthamine and a sweetening agent","volume":"22","author":"Proskurnina","year":"1957","journal-title":"J.\u00a0Gen. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib130","first-page":"621","article-title":"Galanthamine derivatives for the treatment of Alzheimer's disease","volume":"21","author":"Bores","year":"1996","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2013.09.050_bib131","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","article-title":"Galantamine: a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease","volume":"8","author":"Lilienfeld","year":"2002","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejmech.2013.09.050_bib132","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/mol.61.5.1222","article-title":"The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system","volume":"61","author":"Santos","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib133","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/S0960-894X(03)00397-4","article-title":"Synthesis and structure activity relationships of open d-ring galanthamine analogues","volume":"13","author":"Herlem","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib134","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejmech.2008.04.018","article-title":"Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors","volume":"44","author":"Jia","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1527-3458.1998.tb00059.x","article-title":"The pharmacology of physostigmine","volume":"4","author":"Triggle","year":"1998","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejmech.2013.09.050_bib136","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.bmcl.2010.01.097","article-title":"Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities","volume":"20","author":"Zhan","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib137","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02244888","article-title":"Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze","volume":"112","author":"Iijima","year":"1993","journal-title":"Psychopharmacology (Berlin, Germany)"},{"key":"10.1016\/j.ejmech.2013.09.050_bib138","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archopht.1997.01100160027004","article-title":"Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes","volume":"115","author":"Linden","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib139","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/jm060293s","article-title":"Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-Alzheimer drug ganstigmine (CHF-2819)","volume":"49","author":"Bartolucci","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib140","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1021\/jm010080x","article-title":"Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure\/activity relationships for acetyl and butyrylcholinesterase inhibitory action","volume":"44","author":"Yu","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib141","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/157488909787002582","article-title":"Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease","volume":"4","author":"Orhan","year":"2009","journal-title":"Recent Pat. CNS Drug Discovery"},{"key":"10.1016\/j.ejmech.2013.09.050_bib142","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.bmcl.2010.01.097","article-title":"Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities","volume":"20","author":"Zhan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib143","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/jm049309+","article-title":"Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine","volume":"48","author":"Luo","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib144","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1016\/j.bmc.2005.04.030","article-title":"New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids","volume":"13","author":"Viegas","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib145","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/0040-4020(95)00254-6","article-title":"Bioactive and other piperidine alkaloids from Cassia leptophylla","volume":"51","author":"Bolzani","year":"1995","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2013.09.050_bib146","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/np0303963","article-title":"Further bioactive piperidine alkaloids from the flowers and green fruits of Cassia spectabilis","volume":"67","author":"Viegas","year":"2004","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2013.09.050_bib147","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1055\/s-2003-43201","article-title":"Antinociceptive profile of (\u2212)-spectaline: a piperidine alkaloid from Cassia leptophylla","volume":"69","author":"Alexandre-Moreira","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2013.09.050_bib148","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2174\/0929867033456747","article-title":"Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional Chinese medicine origin for the treatment of Alzheimer's disease","volume":"10","author":"Jiang","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib149","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0968-0896(98)00015-7","article-title":"Synthesis and evaluation of tacrine\u2013huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease","volume":"6","author":"Badia","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0028-3908(03)00071-6","article-title":"Characterisation of the anticholinesterase activity of two new tacrine\u2013huperzine A hybrids","volume":"44","author":"Mar Alcala","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2013.09.050_bib151","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/jm0496741","article-title":"Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors","volume":"48","author":"Camps","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib152","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.bmc.2005.03.045","article-title":"Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme","volume":"13","author":"Andrade","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib153","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bmc.2006.10.026","article-title":"Preparation of secolycorines against acetylcholinesterase","volume":"15","author":"Lee","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib154","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.bmcl.2006.01.067","article-title":"Isoquinoline derivatives as potential acetylcholinesterase inhibitors","volume":"16","author":"Markmee","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00044-008-9122-3","article-title":"Evaluation of a new lead for acetylcholinesterase inhibition","volume":"18","author":"Khorana","year":"2009","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2013.09.050_bib156","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3987\/COM-97-7935","article-title":"Studies on inhibitory activity against acetylcholinesterase of new bisbenzylisoquinoline alkaloid and its related compounds","volume":"45","author":"Ogino","year":"1997","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2013.09.050_bib157","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.bmcl.2005.04.005","article-title":"Synthesis of tricyclic analogs of stephaoxocanidine and their evaluation as acetylcholinesterase inhibitors","volume":"15","author":"Bianchi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib158","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/jm049515h","article-title":"Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation","volume":"48","author":"Belluti","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib159","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bmc.2006.09.026","article-title":"Acetylcholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[\u03c9-(benzylmethylamino)alkoxy]xanthen-9-ones","volume":"15","author":"Piazzi","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ptr.3023","article-title":"Acetyl cholinesterase inhibitory potential of a carbazole alkaloid, mahanimbine, from Murraya koenigii","volume":"24","author":"Kumar","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejmech.2013.09.050_bib161","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/0264-6021:3430419","article-title":"Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer \u03b2-amyloid fibril formation","volume":"343","author":"Howlett","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2013.09.050_bib162","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.bmc.2009.12.035","article-title":"Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors","volume":"18","author":"Huang","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib163","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1021\/jm800577j","article-title":"Inhibition of acetylcholinesterase, \u03b2-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush","volume":"51","author":"Rosini","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib164","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/S0040-4039(02)00465-3","article-title":"Terrelactone-A, a novel mero terpenoid with anti-acetyl cholinesterase activity from Aspergillus terreus","volume":"43","author":"Kim","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bmcl.2004.10.067","article-title":"Isoterreulactone A, a novel meroterpenoid with anti-acetylcholinesterase activity produced by Aspergillus terreus","volume":"15","author":"Yoo","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib166","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.ejmech.2011.02.073","article-title":"New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid \u03b2-aggregation","volume":"46","author":"Rouleau","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib167","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.bmc.2004.03.002","article-title":"Kinetics and structure\u2013activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases","volume":"12","author":"Khalid","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib168","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1021\/jm0309194","article-title":"Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna","volume":"46","author":"Zaheer-ul-Haq","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib169","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ejmech.2005.03.011","article-title":"p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors","volume":"40","author":"Correa-Basurto","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib170","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0960-894X(03)00198-7","article-title":"Synthesis, anticholinesterase activity and structure\u2013activity relationships of m-aminobenzoic acid derivatives","volume":"13","author":"Trujillo-Ferrara","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib171","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1016\/j.bmcl.2006.05.030","article-title":"Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease","volume":"16","author":"Sadashiva","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib172","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0928-0987(03)00023-X","article-title":"Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase","volume":"18","author":"Trujillo-Ferrara","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib173","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1211\/0022357021855","article-title":"Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors","volume":"55","author":"Alpt\u00fcz\u00fcn","year":"2003","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib174","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bmc.2005.08.034","article-title":"Search for dual function inhibitors for Alzheimer's disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their A\u03b2-fibril formation inhibition capacity","volume":"14","author":"Kapkova","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ardp.200300795","article-title":"Synthesis, biological activity and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type","volume":"336","author":"Kapkova","year":"2003","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2013.09.050_bib176","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1021\/jm0508639","article-title":"Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition","volume":"48","author":"Pietsch","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib177","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bmc.2004.09.059","article-title":"Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives","volume":"13","author":"Darvesh","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib178","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1021\/jm060682m","article-title":"Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterase with dirigible selectivity toward butyrylcholinesterase","volume":"49","author":"Decker","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib179","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.bmc.2005.10.044","article-title":"Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase","volume":"14","author":"Decker","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib180","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/jm801657v","article-title":"The crystal structure of a complex of acetylcholinesterase with bis-(\u2212)-nor-meptazinol derivative reveals disruption of the catalytic triad","volume":"52","author":"Paz","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib181","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.ejmech.2009.04.042","article-title":"Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase","volume":"44","author":"Girisha","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib182","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/S0968-0896(99)00213-8","article-title":"Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure\u2013activity relationships for inhibitions by aryl carbamates","volume":"7","author":"Lin","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib183","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bmcl.2004.12.058","article-title":"A\u00a0rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates","volume":"15","author":"Lin","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib184","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0223-5234(01)01324-1","article-title":"Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease","volume":"37","author":"Mustazza","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib185","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.bmcl.2005.05.132","article-title":"Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors","volume":"15","author":"Sheng","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib186","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1248\/bpb.33.267","article-title":"Selective cholinesterase inhibitory activities of a new monoterpene diglycoside and other constituents from Nelumbo nucifera stamens","volume":"33","author":"Jung","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2013.09.050_bib187","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1515\/znc-2010-7-804","article-title":"Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius","volume":"65","author":"Seidl","year":"2010","journal-title":"Z.\u00a0Naturforsch. C"},{"key":"10.1016\/j.ejmech.2013.09.050_bib188","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cbi.2010.05.002","article-title":"Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in\u00a0vitro","volume":"187","author":"Guo","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2013.09.050_bib189","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1016\/j.ejmech.2009.03.045","article-title":"New potential AChE inhibitor candidates","volume":"44","author":"De Paula","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib190","first-page":"1","article-title":"Metrifonate for Alzheimer's disease","volume":"2","author":"L\u00f3pez-Arrieta","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2013.09.050_bib191","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","article-title":"A\u00a0review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib192","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.ejmech.2009.01.021","article-title":"Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase\/butyrylcholinesterase","volume":"44","author":"Tang","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib193","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1515\/znc-2010-7-804","article-title":"Eletefine, a stephaoxocane alkaloid from Cissampelos glaberrima","volume":"61","author":"Da-Cunha","year":"1998","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2013.09.050_bib194","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/np960371m","article-title":"2-N-Methylexcentricine, a new alkaloid from roots of Stephania excentrica","volume":"60","author":"Deng","year":"1997","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2013.09.050_bib195","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/np960381n","article-title":"Stephaoxocanine, a novel dihydroisoquinoline alkaloid from Stephania cepharantha","volume":"59","author":"Kashiwaba","year":"1996","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2013.09.050_bib196","doi-asserted-by":"crossref","first-page":"10575","DOI":"10.1016\/j.tet.2004.08.033","article-title":"Synthetic approaches to carnigine, a simple tetrahydroisoquinoline alkaloid","volume":"60","author":"Kaufman","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2013.09.050_bib197","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/S0024-3205(02)02034-9","article-title":"Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts","volume":"71","author":"Lopez","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2013.09.050_bib198","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-969916","article-title":"Inhibition of acetylcholinesterase activity by some isoquinoline alkaloids","volume":"48","author":"Ulrichova","year":"1983","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2013.09.050_bib199","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1016\/j.ejmech.2011.08.002","article-title":"Hybrids of oxoisoaporphine\u2013tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced b-amyloid aggregation inhibitors","volume":"46","author":"Tang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib200","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm201460y","article-title":"New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and \u03b2-amyloid-reducing properties","volume":"55","author":"Fern\u00e1ndez-Bachiller","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.050_bib201","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1016\/j.bmcl.2010.08.044","article-title":"Synthesis and in\u00a0vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease","volume":"20","author":"Korabecny","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.050_bib202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-386467-3.00010-8","article-title":"A\u00a0novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor","volume":"100","author":"Weinreb","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejmech.2013.09.050_bib203","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bmc.2010.01.071","article-title":"Targeting Alzheimer's disease: novel indanone hybrids bearing a pharmacophoric fragment of AP2238","volume":"18","author":"Rizzo","year":"2010","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T18:31:50Z","timestamp":1646677910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413006314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":203,"alternative-id":["S0223523413006314"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.050","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}